Australia markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0200+0.0067 (+50.38%)
At close: 07:14PM GMT
Full screen
Previous close0.0133
Open0.0135
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0135 - 0.0240
52-week range0.0101 - 1.8280
Volume1,175,058
Avg. volume182,444
Market cap18,251
Beta (5Y monthly)1.59
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

    Invitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

  • Zacks

    What Makes Invitae (NVTA) a New Buy Stock

    Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • Motley Fool

    Better Growth Stock: CRISPR Therapeutics vs. Invitae

    Now is a great time to load up on growth stocks because they may be among the first to benefit in the next bull market. You'll find a lot of these candidates in the area of biotech, and two possibilities that come to mind right now are gene-editing company CRISPR Therapeutics (NASDAQ: CRSP) and genetic-testing specialist Invitae (NYSE: NVTA). Which is the better growth stock to buy now?